---
$id: https://graph.org.ai/products/commodity/51111631
$type: Product
source: UNSPSC
code: "51111631"
title: "Dezaguanine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dezaguanine

**UNSPSC Code**: 51111631
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist with the molecular formula C6H6N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9DRB973HUI, chemically known as 6-aminoimidazo(4,5-c)pyridin-4(5h)-one but generally known as dezaguanine, which bears US NIH Compound Identifier 55710. European Medicines Agency schedules Dezaguanine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07057MIG. The term DEZAGUANINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). DEZAGUANINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dezaguanine under HS 29337900 and SITC 51561. As of Q4 2014, DEZAGUANINE remains the US FDA Preferred Term for this commodity. Dezaguanine bears US NLM identifiers UMLS ID C0047332 and NCI Concept Code C968. SMILES: O=C1[NH]C(N)CC2[NH]CNC12.

